Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-25 @ 11:22 PM
Study NCT ID:
NCT00329459
Status:
COMPLETED
Last Update Posted:
2016-10-24
First Post:
2006-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2006-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-22
First Submit QC Date:
None
Study First Post Date:
2006-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-20
Last Update Post Date:
2016-10-24
Last Update Post Date Type:
ESTIMATED